Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 89
6
Biographical Sketches
K ENT BLAIR is a Vic - President of Donaldson, Lufkin dc
Jenrette Securities Corporation. He holds a B.A. from Colgate
University and an M.S. in industrial administration from Carnegie-
Alellon University. Mr. Kent was employed by Merck dc Co., Inc.
from 1963 to 1968, where he held a number of positions in sales,
marketing, production, and finance. In 1968 he joined the
i nstitutional investment research firm of Auerbach, Pollack dc
Richardson as a Vice-President and Director, serving as the health
industries analyst.
C HARLES C. EDWARDS is President of Scripps Clinic and
Research Foundation. Dr. Edwards holds a B.A. and M.D. from the
Un iversity of Colorado and an M.A. from the University of
Minnesota. During his career, he has been in private practice as a
surgeon, served on the staff of The George Washington University,
and was a Vice-President and Managing Officer at Booz, Allen, dc
Hamilton. Or. Edwards was also the Commissioner of the Food
and Drug Administration from 1969 to 1973 and Assistant
Secretary for Health, Education, and Welfare from 1973 to 1975.
Dr. Edwards serves on a number of professional committees and
b cards including service as president of the National Health
Council, trustee~t-large of the National Kidney Foundation, and a
member of the Policy Advisory Committee of the National Board
of Medical Examiners.
W ILLIAM N. HUBBARD, JR. is President of the Upjohn
Company, Inc. He received an A.B. from Columbia University, did
postgraduate work at the University of North Carolina School of
Medicine, and received an M.D. from New York University. Dr.
Hubbard has taught at several universities and was the dean of the
University of Michigan Medical School. He joined Upjohn in 1970
and has served as its President since 1974. Dr. Hubbard's
professional memberships include the National Science Board of
89
OCR for page 90
9o
the National Science Foundation, the New York Academy of
Medicine, and the Board of Regents of the National Library of
M edicine.
PETER B. HUTT is a Partner in Covington and Burling. He
received a B.A. from Yale, an L.L.B from Harvard, and an L.L.M.
from New York University. From 1971 to 1975 he served as Chief
Counsel for the FDA and Assistant General Counsel for HEW. Mr.
Hutt is a member of a number of professional and honorary
societies including the National Academy of Sciences' Institute of
Medicine. He has received a number of awards including the HEW
Distinguished Service award and the Underwood-Prescott award
from MIT. He is the comuthor of Dealing with Drug Abuse.
PHILIP R. LEE is Professor of Social Medicine and th e
Hi rector of the Health Policy Program at the University of
California Medical School, San Francisco. He received an A.B.
from Stanford and an M.D. and M.S. from the University of
-
~ . . ~ ~ ~ ~ ~ 1
Minnesota. Alter working several years al Tne resew fork
University Schoolof Medicine and the Palo Alto Medical Clinic,
Dr. Lee served as Deputy Assistant Secretary and as Assistant
Secretary of Health and Science Affairs at the U.S. Department of
Health, Education, and Welfare from 1 965 to 1969. He has
received a number of awards including the AID Superior Honor
award, is a member of several professional societies, and has
contributed to a number of medical and scientific journals.
ARTHUR M. SACKLER is a research professor of Psychiatry
at New York Medical College and the Publisher of the Medical
Tribune Newspapers. He holds a B.S. and an M.D. from New York
University. Dr. Sackler has been the founder or co-founder of a
number of institutions including the Creedmoor Institute to r
Psvchobiolo~ical Studies and the Sackler School of Medicine in
_ . . . . . . , . . · . · . ~
~l~el-Avlv. He has spent much OI nls career In psycnlaTry ana In
promoting medical communication as Chairman of the Board of
the Medical Press. Inc. and President of the Physicians News
,
Service, Inc. and the Medical Radio and TV Institute, Inc. Dr.
Sackler has received a number of awards and is a member of
numerous professional organizations including a Fellow of the
American Psychiatric Association and an Associate of the Linus
Pauling Institute of Science and Medicine.
LEWIS H. SARETT has recently retired as Senior Vice-
President of Merck & Co., Inc. He holds a B.S. and D.Sc. from
Northwestern and a Ph.D. from Princeton. Dr. Sarett has spent
most of his professional career with Merck dc Co., having worked
as Assistant Director of Organic and Biological Research, as
OCR for page 91
91
Vi cc-President for Basic Research, and as President of Merck
Sharp dc Dohme Research Laboratories. A member of a number of
professional and honorary organizations including the National
Academy of Sciences, Dr. Sarett has received numerous awards
including the Perkin Medal, the Merck Directors award, the
William Scheele Lecture award of the Royal Pharmaceutical
Institute in Sweden, the Northwestern Alumni Association Award
of Merit, and an American Chemical Society award for creative
w ark in synthetic organic chemistry. - He has served on the
Chemical and Engineering News editorial board and has
contributed numerous articles to professional publications.
LACY GLENN THOMAS is Professor of Business at the
Columbia University Graduate School of Business. He holds a B.A.
from Vanderbilt University and an M.A. and Ph.D. from Duke
University. Dr. Thomas held a position at the University of Illinois
as Professor of Economics and was a research fellow at The
Brookings Institution. He is the author or co author of several
papers and articles including "Estimating the Effects of
Regulation on Innovation: An International Comparative Analysis
of the Pharmaceutical Industry" published in the Journal of Law
and Economics.
WILLIAM M. WARDELL is Professor of Pharmacology and
Director of the Center for the Study of Drug Development at the
University of Rochester Medical Center. He has attended
Canterbury University and Otago University Medical School in
New Zealand, holds a B.S. in physiology; a D.Phil. (Ph.D.) and a
B.M., B.Ch. (M.D.) from the University of Oxford (U.K.~; and a
D.M. from the University of Rochester/Oxford. Dr. Wardell is a
member of a number of professional and honorary societies
including the Chairman of the Committee on Drug Development,
National Council on Drugs, and the Corr mittee on Certification in
Clinical Pharmacology, American Society for Clinical Pharma-
cology and Therapeutics. He is the author or coauthor of nearly
100 papers and articles and has received several awards and honors
including the University of Oxford Radcliffe Prize for Research in
Medical Science and the Merck International Fellowship in Clinical
Pharmacology.
PAUL F. WEHRLE is Hastings Professor of Pediatrics at the
University of Southern California and Director of Pediatrics,
Pediatric Pavilion, Los Angeles County-University of Southern
California Medical Center. He holds a B.S. from the University of
Arizona and an A4.D. from Tulane University. Dr. Wherle has held
university appointments at the University of Pittsburgh, The Johns
Hopkins University, and the State University of New York
OCR for page 92
92
at Syracuse. He is author or coauthor of over 190 contributions
concerning infectious disease or environmental hazards and is a
m ember of a number of professional societies including the
Infectious Disease Society of America, the Society for Pediatric
R esearch, the American Association for the Advancement of
Science, and the American Academy of Pediatrics. Dr. Wehrle has
served as a member of numerous committees and organizations
including the World Health Organization and the Expert Com-
mittee on Viral Infections.
A LBERT P. WILLIAMS is Director of the Health Sciences
Program at The Rand Corporation. His formal education includes
a B.S. in engineering from the U.S. Naval Academy and an M.A. in
international relations, an M.A . in economics, and a Ph.D. i n
economics from the Fletcher School of Tufts University. Before
joining The Rand Corporation, Dr. Williams served on the White
House staff and at the Bureau ~ the Budget. He received the
Executive Office of the President Bureau of the Budget Profes-
sional Achievement Award and is a member of several profess
signal organizations including the American Association for the
Advancement of Science and the American Economic Association.
RICHARD D. WOOD is Chairman of the Board and Chief
Executive Officer of Eli Lilly & Co. He holds a number of degrees
including a B.S. from Purdue, an L.L.D. and M.B.A. from the
University of Pennsylvania, an L.L.D from De Pauw University, an
L.L.D. from the Philadelphia College of Pharmacy and Science,
and a D.Sc. from Butler University. Dr. Wood has managed and
directed Eli Lilly operations in Argentina, Mexico, and Central
America. In 1970 he became President of Eli Lilly International
Corporation and Chairman of the Board in 1973. Dr. Wood is a
m ember of several business and professional organizations
including the Business Roundtable, the Conference Board, and the
Pharmaceutical Manufacturers' Association.
ALEJANDRO ZAFFARONI is President and Director of
Research of ALZA Corporation. He holds a B.S. from the
University of Montevideo and a Ph.D. in biochemistry from the
University of Rochester. Before founding ALZA in 1968, Dr.
Zaffaroni progressed from Associate Director of Biological
Research to President of Syntex Laboraties and Syntex Research.
In 1972 Dr. Zaffaroni founded Dynapol, a company with a primary
aim of developing safe food additives. He has received numerous
awards including election as a member of the National Academy
of Sciences' Institute of Medicine, Fellow of the American
Academy of Arts and Sciences, and Fellow of the American
Pharmaceutical Association.
Representative terms from entire chapter:
awards including
